Detalhe da pesquisa
1.
Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(10): 2152-2156, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29800615
2.
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis.
Eur J Haematol
; 101(3): 305-317, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29791053